It’s Time for Change.
A new, minimally invasive option for long-lasting bladder control.
When finding the right therapy seems impossible, what’s next? The Altaviva™ implant is your convenient and hopeful next step, with automatic therapy delivery that integrates seamlessly into your life—designed to keep you moving forward, wherever your journey leads.
Trusted Innovation in Bladder Control
Medtronic, the leader in neuromodulation for bladder and bowel control, pioneered the first neuromodulation device for the bladder over three decades ago and continues to innovate, delivering products that are safe, effective, and may help improve your quality of life.1-6,11 13
A Gentle Approach that Works with Your Body
1. Small device placed near the ankle.
2. Sends gentle electrical pulses that may help to restore the communication pathways between the bladder and the brain, 2, 3 which may help reduce urgency with leaks. 1
3. It is a proven therapy for reducing bladder control symptoms. 1,4 8
Benefits
- single minimally invasive procedure9
- no sedation required11
- expected 15 years of therapy10
Is Altaviva™ Right for You?
Who should try it?
The ALTAVIVA™ implant is for adults with UUI who…
- have tried other treatments without success
- want a long-term, minimally invasive solution
- prefer to avoid frequent injections or daily medications
Your Journey to Better Bladder Control
Consultation
Meet your specialist and review symptoms.
Implant
Minimally invasive procedure 9, no sedation 11, walk out on the same day with your therapy activated 10.
Get Your Life Back
Regain control and confidence.
Relief from UUI Symptoms is Possible
Lets talk about whether the Altaviva™ implant is right for you.
References:
1. Medtronic Atltaviva clinical Summary 2025
2. Li X, Li X, Liao L. Mechanism of action of tibial nerve stimulation in the treatment of lower urinary tract dysfunction. Neuromod. 2023;27:256-266
3. Bhide AA, Tailor V, Fernando R, Vik K, Digesu GA. Posterior tibial nerve stimulation for overactive bladder – techniques and efficacy. Int Urolgynecol J. 2020;31:865-70.
4. Peters KM, Carrico DJ, et al. Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SumiT trial. J Urol. 2010;183:1438-1443.
5. Peters KM, MacDiarmid SA, Wooldridge LS, et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol. 2009;182(3):1055-1061.
6. Kobashi K, Nitti V, Margolis E, et al. A prospective study to evaluate efficacy using the NURO percutaneous tibial neuromodulation system in drug-naïve patients with overactive bladder syndrome. J Urol. 2019;131:77-82.
7. Rogers A, Bragg S, Ferrante K, et al. Pivotal study of leadless tibial nerve stimulation with eCoin for urgency urinary incontinence: an open-label, single arm trial. J Urol. 2021;206:399-408.
8. Heesakkers JPFA, Toozs-Hobson P, Sutherland SE, et al. A prospective study to assess the effectiveness and safety of the BlueWind system in the treatment of patients diagnosed with urgency urinary incontinence. Neurourol Urodyn. 2024;43:1491-1503.
9. Cameron AP, Chung DE, Dielubanza EJ et al. The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder (2024). J Urol. 2024;212:11-20.
10. M028929C001RevB – Clinician Therapy and Programming Guide Altaviva™ Model P7850N
11. M028930C001RevB – AltavivaTM Model P7850N Neurostimulator Implant Manual
12. Chancellor MB, Chartier-kastler EJ. Principles of sacral nerve stimulation (SNS) for the treatment of bladder and urethral sphincter dysfunctions. Neuromod. 2000;3(1):15-26.
13. Leng WW, Chancellor MB. How sacral nerve stimulation neuromodulation works. Urol Clin North Am. 2005;32:11-18.
14. Medtronic data on file: T-entry system – Recharge Performance Design Verification Test Report.
15. M028949C001 MRI Guidelines for Altaviva™ Neurostimulator.
US-UP-2500701
